Video
Video course abdominal ultrasound
Examination of abdominal vessels
Aorta longitudinal
Author: Prof. Dr. Christoph F. Dietrich, Caritas Krankenhaus Bad Mergentheim.
© 2015 Falk Foundation e.V., Freiburg. All rights reserved.
Please switch on your loudspeakers!
Link to Falk Mediacenter:
http://media.falkfoundation.de/index.php?id=174&L=1
Link to the video directly:
http://media.drfalkpharma.de/fileadmin/media/73_Abdominal_vessels_Aorta_longitudinal_ENG.mp4
Preview images:
580 x 325 pixels (with arrow)
http://newsletter.drfalkpharma.de/FGI_2-16/Vorschau_Sono_Clip73_E_580P.jpg
580 x 325 pixels (without arrow)
http://newsletter.drfalkpharma.de/FGI_2-16/Vorschau_Sono_Clip73_E_580.jpg
Latest research in brief:
Description field (to be displayed at the end of the structural element):
Bowel
http://newsletter.drfalkpharma.de/Logos/Falk-Darm.png
Text:
Bharucha AE et al, Am J Gastroenterol. 2015;110(11):1589–96
Temporal trends in diverticulitis: Incidence is increasing, particularly in younger patients, but complications are relatively uncommon.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=22136#30940
Text:
Münch A et al, Gut. 2016;65(1):47–56
Collagenous colitis: Low-dose budesonide efficiently maintains clinical remission and quality of life over a period of 1 year.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=22136#c30941
Text:
Coenen MJH et al, Gastroenterology. 2015;149(4):907–17.e7
Thiopurine-associated myelotoxicity in IBD patients: Usefulness of TPMT testing prior to therapy remains controversial.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=22136#c30942
Liver
Biliary Tracts
http://newsletter.drfalkpharma.de/Logos/Falk-Leber.png
Text:
Manka P et al, Clin Gastroenterol Hepatol. 2015;13(10):1836–42
Hepatitis E and acute liver failure: Data from a German University Medical Center indicate that even in Western countries, hepatitis E virus (HEV) infection is an important differential diagnosis in acute liver failure. Serological testing for HEV is not sufficient; HEV RNA should also be determined in order to confirm or rule out HEV infection in patients with acute liver failure of ambiguous etiology.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=22136#c30944
Text:
Ampuero J et al, Gastroenterology. 2015;149(6):1483–9
Liver cirrhosis: Minimal hepatic encephalopathy is associated with a reduced 5-year survival in patients with cirrhosis. Evaluation of minimal hepatic encephalopathy may help to predict survival and improve management of patients with cirrhosis. The critical flicker frequency may be an adequate diagnostic tool for this purpose.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=22136#c30945
Text:
Beste LA et al, Gastroenterology. 2015;149(6):1471–82.e5
Cirrhosis and hepatocellular carcinoma (HCC): Data from the US indicate that cirrhosis prevalence and mortality as well as HCC incidence and mortality increased from 2001 to 2013, driven by hepatitis C with smaller contribution from non-alcoholic fatty liver disease (NAFLD). Cirrhosis prevalence may peak in 2021.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=22136#c30946
Oesophagus
Stomach
Duodenum
http://newsletter.drfalkpharma.de/Logos/Falk-Magen.png
Text:
Saccone G et al, Am J Obstet Gynecol. 2015 [Epub ahead of print]
Celiac disease and pregnancy: Women with celiac disease are at risk for obstetric complications including preterm birth, stillbirth and growth restriction.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=22136#c30947
Text:
Molina-Infante J et al, Am J Gastroenterol. 2015;110(11):1567–75
PPI-responsive esophageal eosinophilia: Long-term loss of response is uncommon and influenced by CYP2C19 genotype and rhinoconjunctivitis.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=22136#c30948
Text:
Asher Wolf W et al, Gastroenterology. 2015;149(7):1752–61.e1
Barrett’s esophagus: very low incidence of esophageal adenocarcinoma and related mortality following radiofrequency ablation.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=22136#c30953
Pancreas
http://newsletter.drfalkpharma.de/Logos/Falk-Pankreas.png
Text:
Krishna SG et al, Am J Gastroenterol. 2015;110(11):1608–19
Acute pancreatitis: Morbid obesity is associated with adverse clinical outcomes including mortality, organ failure and health-care utilization.
Link:
http://www.drfalkpharma.com/index.php?L=1&id=22136#c30956
International Symposia and Workshops
Symposium 201
Gut-Liver Interactions: From IBD to NASH
Bild:
http://newsletter.drfalkpharma.de/Logos/Symposium.jpg
Text:
March 11 – 12, 2016, Innsbruck, Austria
Congress Innsbruck, Rennweg 3, 6020 Innsbruck, Austria
Link1:
http://newsletter.drfalkpharma.de/Programme/2015/S201_Innsbruck_2016_Preliminary_Program.pdf
Link2:
http://newsletter.drfalkpharma.de/Programme/2015/S201_Innsbruck_2016_Registration.pdf
Link für Online-Anmeldung:
http://events.falkfoundation.com/index.php?id=205&L=1
Symposium 202
Evolving Therapies in Clinical Practice in IBD
Bild:
http://newsletter.drfalkpharma.de/Logos/Symposium.jpg
Text:
April 29 – 30, 2016, Prague, Czech Republic
Hilton Prague, Pobrezni 1, 18600 Prague 08, Czech Republic
Link1:
http://newsletter.drfalkpharma.de/Programme/2015/S202_Prague_2016_Preliminary_Program.pdf
Link2:
http://newsletter.drfalkpharma.de/Programme/2015/S202_Prague_2016_Registration.pdf
Link für Online-Anmeldung:
http://events.falkfoundation.com/index.php?id=206&L=1
Current Falk literature:
Ursofalk®
Now also licensed for hepatobiliary disorders in cystic fibrosis
(6 pages)
U16e
Picture:
http://newsletter.drfalkpharma.de/FGI_2-16/U16e_1-4-15.jpg
PDF:
http://newsletter.drfalkpharma.de/FGI_2-16/U16e_1-4-15.pdf
Order by email (Please replace text by your email address):